A
$ Value
$0
Shares
1,160
Price
$0
Filed
Nov 13
Insider
Name
Dahl Andrew M.
Title
SVP, Corporate Controller
CIK
0002022347
Roles
Officer
Transaction Details
Transaction Date
2025-11-13
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,183
Footnotes
These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Filing Info
Dahl Andrew M.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-22 | EW | F | $14K |
| 2025-11-13 | EW | A | $0 |
| 2025-09-13 | EW | F | $20K |
| 2025-05-08 | EW | A | $0 |
| 2025-05-08 | EW | A | $0 |
Other Insiders at EW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
BOBO DONALD E JR
CVP,Strategy/Corp Development
|
— | $4.8M | 2026-04-02 |
|
Ullem Scott B.
CVP, Chief Financial Officer
|
— | $2.1M | 2026-04-09 |
|
Zovighian Bernard J
CEO
|
— | $1.7M | 2026-02-13 |
|
Lippis Daniel J.
CVP, TAVR
|
— | $170K | 2026-04-06 |
|
Dahl Andrew M.
SVP, Corporate Controller
|
— | — | 2026-02-22 |